Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

Temporal trends in mortality from hematological cancers with atrial fibrillation and flutter as contributing causes in the United States, 2000–2020: A national vital statistics system analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

MPManas PustakeLKLakshmi KattamuriADAbhizith Deoker

Discussion

Loading...

Member takes

Overview

Cross-sectional analysis identifies rising mortality trends in hematological cancers with atrial fibrillation, indicating significant health impacts through thromboembolic events and heart failure in

Key Points

  • Mortality increased by 300% among patients with hematological cancers and comorbid atrial fibrillation and flutter.
  • Joinpoint regression revealed distinct mortality phases from 1999 to 2020, with inflection points leading to accelerated trends post-2011.
  • Analysis utilized National Vital Statistics data and involved Poisson regression models to forecast mortality rates and assess demographic disparities.
  • Significant sex and racial inequities were noted, emphasizing the need for targeted screening and interventions in high-risk populations.

Cite This Study

Pustake et al. (2025) studied this question.

synapsesocial.com/papers/69362f5d4fa91c937236dbf2https://doi.org/10.1182/blood-2025-6404
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cancer and atrial fibrillation mortality: worsening national trends over 25 years2026
  2. 2Trends in thromboembolism-related mortality among patients with hematologic malignancies in the u.S., 1999–2023: A CDC wonder analysis2025 · 1 citations
  3. 3Abstract Fri091: Unraveling the Rising Tide: Trends and Disparities in Atrial Fibrillation Mortality in the United States, 1968–20232025
  4. 4Atrial fibrillation mortality among patients with neoplasms: National trends and deep learning forecast through 2038.2026
  5. 5Retrospective analysis in mortality from phlebitis/thrombophlebitis and atrial fibrillation/flutter in u.S. adults aged ≥45 years from 1999–2023: A CDC wonder study2025